Science
Mechanism of Action
This ingredient functions by slowly decomposing in aqueous environments, gradually releasing small quantities of formaldehyde. Formaldehyde acts as a potent antimicrobial agent, disrupting the essential cellular processes of bacteria, yeasts, and molds to prevent their proliferation. Additionally, Imidazolidinone contributes to product stability and acts as a humectant, aiding in moisture retention within formulations.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Demonstrated a significant dose- and time-dependent decrease in HL60 cell viability after 3, 6, or 24 hours of incubation, indicating potential cytotoxicity.
- 02 Evaluated as sensitizing in a local lymph node assay (LLNA) in dimethylformamide, showing stimulation indices greater than 3 at 25% and 50% concentrations.
- 03 Determined as the optimal patch test concentration in a hydrophilic dried-in vehicle (TRUE test) for detecting Imidazolidinyl Urea allergy.
Transparency
Dusting Analysis
Imidazolidinone is a preservative, not an active ingredient for direct skin benefits, therefore 'dusting' is not applicable. However, adherence to the maximum authorized concentration of 0.6% is crucial, as higher levels present a red flag for potential irritation or sensitization.
The Formula
Formulation
Stability
Imidazolidinone remains effective across a broad pH range of 3.0 to 9.0. The rate of formaldehyde release is dependent on the product matrix, pH, temperature, and duration of exposure. It can facilitate nitrosamine formation at temperatures exceeding 10°C, thus requiring the co-formulation with nitrosamine inhibitors (e.g., Vitamin E or C at 100-1000 µg/ml) and storage under cool, amber conditions.
Synergies
- Nitrosamine inhibitors (e.g., Vitamin E, Vitamin C) to prevent nitrosamine formation.
Conflicts
- Oxidizing agents
- Highly acidic materials
- Highly alkaline materials
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel has repeatedly affirmed Imidazolidinone as safe for use in cosmetics, and its use is approved by the FDA and the European Commission. The EU mandates a maximum authorized concentration of 0.6% in ready-for-use preparations. It is a known formaldehyde-releaser, and while typically within safe limits at regulated concentrations, it can act as a potential irritant. Individuals with sensitive skin or atopic conditions may experience mild irritation or allergic contact dermatitis. Global studies indicate positive sensitization rates in patch-tested individuals ranging from 0.3% to 8.1%. The Australian NICNAS classifies it as a hazardous substance for skin sensitization above 1%.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While an effective and regulated preservative, Imidazolidinone's mechanism of formaldehyde release and documented potential for irritation and sensitization, particularly for sensitive individuals, positions it as a questionable choice for precision skincare formulations aiming for maximal skin compatibility.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources